Why am I not losing weight on a GLP-1?

Common reasons progress stalls or never starts: dose, time, intake, muscle, sleep, other conditions — and the possibility of being a non-responder.

Few things are more demoralising than doing everything asked and seeing nothing. The useful version of this article is not reassurance — it is the list of things that actually explain it, roughly in order of how often each turns out to be the answer.

1. You are early

The most common explanation. The approved labels describe the starting dose as a dose to let the body adjust rather than a treatment dose, and titration proceeds at intervals of at least four weeks. If you are in the first month or two, you may simply not be at a dose that does much yet.

2. The dose has not been optimised

The dose a clinician settles on is the lowest that is working. If nothing is working, that is a reason for them to reconsider the dose — upward, within the labelled range. This is the single most common actionable cause and it requires a clinician, not a decision by you.

3. You are eating too little, not too much

Counterintuitive and genuinely common. Very low intake drives fatigue and accelerates lean mass loss, and losing muscle lowers the rate at which you use energy at rest. People eating almost nothing, exhausted, losing strength and seeing no movement are in a worse position than people eating properly — and the fix is to eat more, deliberately, with protein.

4. Protein and resistance training are missing

Related to the above and worth separating. Without protein and training, more of what is lost is lean mass, which makes the whole process harder over time. This is the item with the clearest mechanism and the most reliable payoff.

5. Something else is going on

• Sleep. Poor or short sleep measurably worsens appetite regulation. It is the most underrated item on this list.
• Other medications. Several commonly prescribed drugs affect weight; your clinician can review them.
• Thyroid, hormonal or other conditions, including PCOS and hypothyroidism, which may be untreated.
• Alcohol, which is easy to underestimate.
• Stress and the eating patterns that come with it.

6. You may be a non-responder

This is real and it is not talked about enough. Not everyone responds to a given GLP-1, even at an appropriate dose with everything else in place. Trials of the approved products report a range of responses including people who do not respond meaningfully. It is a recognised clinical outcome, not a verdict on your effort.

What follows from it is practical: a clinician may consider a different molecule, reconsider the dose, look for an untreated contributor, or conclude that this class is not the right tool for you. All of those are legitimate.

What not to do

Do not increase your dose yourself, do not double after a missed dose, and do not cut intake further. The first two are unmonitored dose changes; the third usually makes things worse. If you are tempted by any of them, that is the moment to message your care team instead.

GLP does not publish expected results. The figures in circulation come from trials of the FDA-approved products on their approved schedules, averaged across thousands of participants — they do not describe a compounded preparation, a lower dose, or you. A service that tells you what you will achieve is telling you something it cannot know.

This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.